Latest revenue
$244.1M
as of 2025-12-28
Latest net income
$14.3M
as of 2025-12-28
Net margin
5.9%
as of 2025-12-28
Community sentiment
Where do you think HWKN is heading?
Keep private notes on HWKN — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
HWKN vs S&P 500 · rebased to 100
Live market
delayed ≤15 min- Market cap
- $3.25B
- Enterprise value
- $3.49B
- P/E (trailing)
- 39.8×
- Forward P/E
- —
- P/B
- 6.08×
- Dividend yield
- 0.5%
- 52-wk high
- $186.15
- 52-wk low
- $117.98
- Beta
- —
- Shares out
- 20.9M
What this company does
ITEM 1. BUSINESS We are a leading water treatment and specialty ingredients company that formulates, manufactures, distributes, and blends products for our Water Treatment, Food and Health Sciences, and Industrial Solutions customers. We believe that we create value for our customers through superb service and support, quality products, personalized applications and trustworthy, creative employees. We conduct our business in three segments: Water Treatment, Food and Health Sciences, and Industrial Solutions. Water Treatment Segment. Our Water Treatment Group specializes in providing chemicals, filtration media and systems, equipment, services and solutions for potable water, municipal and…
AI summary unavailable — showing raw filing excerpt
Generated from HWKN's filing dated 2026-05-13
Key risks
ITEM 1A. RISK FACTORS You should carefully consider the following material factors regarding risks relating to an investment in our securities and when reading the information, including the financial information, contained in this Annual Report on Form 10-K. Shareholders are cautioned that these and other factors may affect future performance and cause actual results to differ materially from those that may be anticipated. COMPETITIVE AND REPUTATIONAL RISKS We operate in a highly competitive environment and face significant competition and price pressure. We operate in a highly competitive industry and compete with producers, manufacturers, distributors and sales agents offering products…
AI summary unavailable — showing raw filing excerpt
Generated from HWKN's filing dated 2026-05-13
ActaClear Score
Computed from 5 years of SEC fundamentals + latest market data, ranked within Wholesale-Chemicals & Allied Products (2 peers). 10 = best in industry, 5 = median, 0 = worst. Refreshed Jun 10, 2026.
Fair value · DCF
Methodology + caveats (click to expand)
Method. 10-year forecast of free cash flow, discounted at the company's WACC, with a Gordon-growth terminal at year 10. FCF is proxied by last fiscal-year net income (proper FCF needs CFO − CapEx by year, which we don't store yet). Beta defaults to 1.0 when not reported.
Why DCF is fragile. Treat the output as a thinking aid, not a verdict. Honest weaknesses of any DCF:
- Growth is the dominant assumption. No one can foresee 10 years of growth — small changes in the slider can double or halve fair value. The reverse-DCF readout above tells you what the market is implicitly assuming; ask yourself whether that's realistic before trusting either number.
- Terminal value dominates. In most DCFs, 60-80% of the answer comes from the terminal-value calculation — i.e., everything AFTER year 10. A 0.5pp change in terminal growth, or in WACC, can swing fair value by 20-30%.
- WACC is itself a guess. We use a textbook CAPM cost of equity (Rf 4.3%, MRP 5.5%, β from the quote) plus a 6% pretax cost of debt — none of these are the company's actual marginal financing cost.
- No moat / disruption modelling. The model assumes the company keeps earning whatever it earns today, compounding cleanly. Competitive shifts, regulatory action, and technology disruption can invalidate the forecast overnight.
- Net income ≠ free cash flow. For capex-heavy names (semis, telcos) net income overstates distributable cash. For low-capex names (software) it understates. Both reduce the precision of the FV figure.
- Reflexivity. A high stock price often becomes a self-fulfilling prophecy via better hiring, financing, and customer trust. DCF can't see this.
Take the DCF, the reverse-DCF implied growth, the historical multiples, and the community sentiment together. When they agree, conviction. When they disagree, the disagreement is the most informative thing on the page.
Historical multiples
How does HWKN's current valuation compare to its own past?
P/E uses year-end weekly close ÷ (net income ÷ shares outstanding today). Held shares constant at today's count, which understates the per-share earnings improvement from buybacks over the period. PEG uses 5y revenue CAGR as a proxy for EPS growth — close, but not identical (margin expansion or dilution can drive a wedge). Best read as a comparator across companies and industries, not as a precise replica of historical multiples.